Cui, X <br/><br/>
Combination treatment of stroke with sub-therapeutic doses of Simvastatin and human umbilical cord blood cells enhances vascular remodeling and improves functional outcome.  [electronic resource] 

 -  Neuroscience  Dec 2012 
 - 223-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7544 
<br/><br/><label>Standard No.: </label>10.1016/j.neuroscience.2012.09.066  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analysis of Variance<br/>Angiopoietins--immunology<br/>Animals<br/>Antibodies--pharmacology<br/>Anticholesteremic Agents--therapeutic use<br/>Arteries--cytology<br/>Bromodeoxyuridine<br/>Cell Movement--drug effects<br/>Cells, Cultured<br/>Disease Models, Animal<br/>Human Umbilical Vein Endothelial Cells--cytology<br/>Humans<br/>Lectins--metabolism<br/>Linear Models<br/>Male<br/>Neovascularization, Pathologic--etiology<br/>Neovascularization, Physiologic--drug effects<br/>Rats<br/>Rats, Wistar<br/>Simvastatin--therapeutic use<br/>Stroke--drug therapy<br/>Time Factors